Delay in desmopressin therapy: Disaster in waiting

J Clin Pharm Ther. 2022 Dec;47(12):2376-2378. doi: 10.1111/jcpt.13807. Epub 2022 Nov 14.

Abstract

What is known and objective: Central diabetes insipidus (DI) is a complex disease that requires firm adherence to desmopressin therapy. There is little information on the onset of hypernatremia after withdrawal of desmopressin.

Case summary: We present a case of an elderly woman with central DI whose serum sodium jumped from 141 to 171 mEq/L after 48-72 h of holding oral desmopressin. Her DI crisis resolved with intravenous desmopressin and free water administration.

What is new and conclusion: Based on this precipitous onset of DI crisis, we recommend not withholding desmopressin for more than 24 h.

Keywords: central diabetes insipidus; desmopressin; hypernatremia.

Publication types

  • Case Reports

MeSH terms

  • Administration, Intravenous
  • Aged
  • Deamino Arginine Vasopressin / therapeutic use
  • Diabetes Insipidus, Neurogenic* / drug therapy
  • Disasters*
  • Female
  • Humans
  • Hypernatremia* / therapy

Substances

  • Deamino Arginine Vasopressin